Status:
COMPLETED
Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Parkinson Disease
Eligibility:
All Genders
40-70 years
Brief Summary
Neuropathologically, Parkinson disease (PD) is characterized by the accumulation of intra-neuronal protein aggregates (Lewy bodies and Lewy neurites). It is believed that altered rt-synuclein protein ...
Eligibility Criteria
Inclusion
- Diagnosis of "clinically established PD" based on the MDS clinical diagnostic criteria.
- Age at disease onset will be between 40 and 70.
Exclusion
- severe autonomic dysfunction (as defined in red flag 5a and 5b) will be an exclusion criterion Previous deep brain stimulation is an exclusion criterion.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06156917
Start Date
September 1 2018
End Date
September 1 2020
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italia, Italy